%0 Journal Article
%T Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in combination with standard of care chemotherapy in primarily untreated chemo na£¿ve upper gi-adenocarcinomas with peritoneal seeding ¨C a phase II/III trial of the AIO/CAOGI/ACO
%A Alfred K£¿nigsrainer
%A Beate Rau
%A Clemens Tempfer
%A Ines Gockel
%A Marc Reymond
%A Matthias Schwarzbach
%A Pompiliu Piso
%A Salah-Eddin Al-Batran
%A Stefan P. M£¿nig
%A Thomas Kraus
%A Thorsten Oliver Goetze
%A Ulli Bankstahl
%A Urs Pabst
%A Wolf O. Bechstein
%J Archive of "Pleura and Peritoneum".
%D 2018
%R 10.1515/pp-2018-0113
%X Peritoneal metastasis is a common and dismal evolution of several gastrointestinal (GI) tumors, including gastric, colorectal, hepatobiliary, pancreatic, and other cancers. The therapy of peritoneal metastasis is largely palliative; with the aim of prolonging life and preserving its quality. In the meantime, a significant pharmacological advantage of intraperitoneal chemotherapy was documented in the preclinical model, and numerous clinical studies have delivered promising clinical results
%K intraperitoneal therapy
%K peritoneal carcinomatosis
%K pressurized intraperitoneal aerosol chemotherapy (PIPAC)
%K upper gastrointestinal cancer.
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404998/